NHS: Drugs
The question
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with the Department for Business and Trade on the potential impact of UK-US trade agreements on the price the NHS pays for medicines from American suppliers.
Answered by Ashley Dalton
The Department of Health and Social Care continues to work closely with the Department for Business and Trade to assess the potential impact of the UK-US Economic Prosperity Deal on the life sciences and pharmaceutical sector. The Government is clear that we will only ever sign trade agreements that align with the UK’s national interests and the price the NHS pays for medicines will never be on the table for any trade agreement.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →